March/April 2013

This case study from Avella Wholesale demonstrates the necessary strategies and steps for successful catering to a niche market.

From its creation, Diplomat University at Diplomat Specialty Pharmacy has been structured around its primary objective to provide a high-level of ongoing education to enable staff and partners to take the best possible care of patients.

Despite the challenges faced when treating patients in a senior care setting, specialty drug trend in this population continues to increase. Providing quality, accessible specialty pharmacy services to facilities that care for these patients is of utmost importance as the population in the United States ages and additional complexity is added.

If the biggest impact of the ACA will be on Medicare and one of the biggest changes in Medicare is the accountable care organization (ACO) model, then one could argue that ACOs will have the biggest impact on our health care system.

Discover a revolutionary, efficient, and effective way to amplify the "high touch" of specialty pharmacy with the use of technology as patients embrace new tools to monitor their health.

US manufacturers prepare for expanding biosimilar market opportunities as this exciting landscape takes shape. The production of biosimilars poses challenges as pharma looks to curb health care spending.

Is it time to take sides or stay on the sidelines? With major happenings in specialty pharmacy, specialty pharmacists will want to take note as the profession moves on.

The industry is watching how biosimilars will affect the market and the challenges that lie ahead.

In 2012, the FDA approved 22 specialty medications, up from 18 specialty drug approvals in 2011. This trend is expected to continue for the forseeable future.